Vaccine regimens that activate cellular immunity have been suggested to generate protective responses while also increasing the number of target cells at infection sites [56–58]; in particular, Ad5-specific CD4+ T cells expanded by DNA/rAd5 vaccination have been shown to be highly susceptible to HIV infection [58]. The gene discussed is CD4; the disease is HIV infectious disease.